The interaction of caveolin 3 protein with the potassium inward rectifier channel Kir2.1. PHYSIOLOGY AND PATHOLOGY RELATED TO LONG QT SYNDROME 9 (LQT9).

por Vaidyanathan, Ravi, Vega, Amanda L., Song, Chunhua, Zhou, Qing, Tan, Bi-Hua, Berger, Stuart, Makielski, Jonathan C., Eckhardt, Lee L.
Publicado 2013

Expression defect of the rare variant/Brugada mutation R1512W depends upon the SCN5A splice variant background and can be rescued by mexiletine and the common polymorphism H558R

por Hu, Rou-Mu, Song, Evelyn J., Tester, David J., Deschenes, Isabelle, Ackerman, Michael J., Makielski, Jonathan C., Tan, Bi-Hua
Publicado 2021

Mexiletine rescues a mixed biophysical phenotype of the cardiac sodium channel arising from the SCN5A mutation, N406K, found in LQT3 patients

por Hu, Rou-Mu, Tester, David J., Li, Ryan, Sun, Tianyu, Peterson, Blaise Z., Ackerman, Michael J., Makielski, Jonathan C., Tan, Bi-Hua
Publicado 2018

MiR-215, an activator of the CTNNBIP1/β-catenin pathway, is a marker of poor prognosis in human glioma

por Tong, Yong-Qing, Liu, Bei, Zheng, Hong-Yun, Gu, Jian, Liu, Hang, Li, Feng, Tan, Bi-Hua, Hartman, Melanie, Song, Chunhua, Li, Yan
Publicado 2015

Two novel deleterious variants of Angiotensin‐I‐converting Enzyme gene identified in a family with recurrent anhydramnios

por Wang, Jingwei, Bin, Qiao, Cheng, Biheng, Yan, Li, Xiong, Liang, Tan, Bi‐Hua, McGrath, Mary, Smink, Gayle M., Song, Chunhua, Tong, Yongqing
Publicado 2020

Arrhythmogenic Biophysical Phenotype for SCN5A Mutation S1787N Depends upon Splice Variant Background and Intracellular Acidosis

por Hu, Rou-Mu, Tan, Bi-Hua, Tester, David J., Song, Chunhua, He, Yang, Dovat, Sinisa, Peterson, Blaise Z., Ackerman, Michael J., Makielski, Jonathan C.
Publicado 2015

A novel G6PD deleterious variant identified in three families with severe glucose-6-phosphate dehydrogenase deficiency

por Tong, Yongqing, Liu, Bei, Zheng, Hongyun, Bao, Anyu, Wu, Zegang, Gu, Jian, Tan, Bi-Hua, McGrath, Mary, Kane, Shriya, Song, Chunhua, Li, Yan
Publicado 2020

Dual targeting of MTOR as a novel therapeutic approach for high-risk B-cell acute lymphoblastic leukemia

por Ge, Zheng, Song, Chunhua, Ding, Yali, Tan, Bi-Hua, Desai, Dhimant, Sharma, Arati, Gowda, Raghavendra, Yue, Feng, Huang, Suming, Spiegelman, Vladimir, Payne, Jonathon L., Reeves, Mark E., Iyer, Soumya, Dhanyamraju, Pavan Kumar, Imamura, Yuka, Bogush, Daniel, Bamme, Yevgeniya, Yang, Yiping, Soliman, Mario, Kane, Shriya, Dovat, Elanora, Schramm, Joseph, Hu, Tommy, McGrath, Mary, Chroneos, Zissis C., Payne, Kimberly J., Gowda, Chandrika, Dovat, Sinisa
Publicado 2021